The upward revision in revenue guidance suggests that Atomera's business is performing better than expected, which is a strong positive signal to investors. The validation of MST film deposition by a customer indicates progress towards commercial distribution, which could lead to future revenue growth. The immediate positive reaction in stock price reflects investor optimism about the company's short-term prospects.